November 21, 2023
A perennial challenge in cancer treatment is figuring out how to kill tumor cells while leaving healthy cells unharmed. Our Curious Dr. George asks Stuart L. Marcus, MD, PhD, founder and Chief Science Officer at SonALAsense, how his company’s light-activated drug treatment addresses this challenge, holding potential promise for people with brain, bladder, and possibly other cancers. Curious Dr. George: Your flagship treatment employs… Read more »
September 6, 2022
Brain Tumor Guide BookmarkGeorge Lundberg, MD
The Musella Foundation has announced online availability of the 12th edition of the Brain Tumor Guide for the Newly Diagnosed.
October 22, 2019
Barriers to Accrual and Enrollment in Brain Tumor Trials BookmarkGeorge Lundberg, MD
Research paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:Securing participation in clinical trials is a continuing and serious problem of clinical research for many cancers. This paper describes an effort to improve participation for brain cancer clinical trials.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
August 17, 2019
Diffuse Intrinsic Pontine Glioma (DIPG)—An Overview BookmarkGeorge Lundberg, MD
Curated by Editor in Chief George Lundberg, MD, who notes:
DIPG is a rare, malignant brain tumor. Three hundred Americans, usually children, are diagnosed with DIPG each year. Its location (pons), its sublocation (intrinsic), its growth character (diffuse), and its cell type (glioma) describe a very difficult cancer to treat. Here is how one prestigious cancer center (Dana-Farber Cancer Institute) explains DIPG.